| Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... bmj 369, 2020 | 3336 | 2020 |
| The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and … J Mair-Jenkins, M Saavedra-Campos, JK Baillie, P Cleary, FM Khaw, ... The Journal of infectious diseases 211 (1), 80-90, 2015 | 1204 | 2015 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... bmj 370, 2020 | 1009 | 2020 |
| Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual … SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ... The lancet Respiratory medicine 2 (5), 395-404, 2014 | 726 | 2014 |
| Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ... bmj 370, 2020 | 704 | 2020 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 660 | 2021 |
| Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community J Yan, M Grantham, J Pantelic, PJ Bueno de Mesquita, B Albert, F Liu, ... Proceedings of the National Academy of Sciences 115 (5), 1081-1086, 2018 | 579 | 2018 |
| Middle East respiratory syndrome YM Arabi, HH Balkhy, FG Hayden, A Bouchama, T Luke, JK Baillie, ... New England Journal of Medicine 376 (6), 584-594, 2017 | 534 | 2017 |
| Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised … X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ... The Lancet 398 (10303), 856-869, 2021 | 487 | 2021 |
| Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study AC Hayward, EB Fragaszy, A Bermingham, L Wang, A Copas, ... The Lancet Respiratory Medicine 2 (6), 445-454, 2014 | 483 | 2014 |
| SARS-CoV-2 (COVID-19): what do we know about children? A systematic review NS Mehta, OT Mytton, EWS Mullins, TA Fowler, CL Falconer, OB Murphy, ... Clinical Infectious Diseases 71 (9), 2469-2479, 2020 | 461 | 2020 |
| Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol AB Docherty, EM Harrison, CA Green, H Hardwick, R Pius, L Norman, ... MedRxiv, 2020.04. 23.20076042, 2020 | 445 | 2020 |
| ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... Bmj 369, m1985, 2020 | 386 | 2020 |
| Reduced neutralisation of SARS-CoV-2 omicron B. 1.1. 529 variant by post-immunisation serum W Dejnirattisai, RH Shaw, P Supasa, C Liu, ASV Stuart, AJ Pollard, X Liu, ... The Lancet 399 (10321), 234-236, 2022 | 363 | 2022 |
| Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults B Killingley, AJ Mann, M Kalinova, A Boyers, N Goonawardane, J Zhou, ... Nature Medicine 28 (5), 1031-1041, 2022 | 355 | 2022 |
| The epidemiology and clinical impact of pandemic influenza JS Nguyen-Van-Tam, AW Hampson Vaccine 21 (16), 1762-1768, 2003 | 339 | 2003 |
| Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009) JS Nguyen-Van-Tam, PJM Openshaw, A Hashim, EM Gadd, WS Lim, ... Thorax 65 (7), 645-651, 2010 | 325 | 2010 |
| Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data RH Shaw, A Stuart, M Greenland, X Liu, JSN Van-Tam, MD Snape The Lancet 397 (10289), 2043-2046, 2021 | 324 | 2021 |
| Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study J Hippisley-Cox, CAC Coupland, N Mehta, RH Keogh, K Diaz-Ordaz, ... bmj 374, 2021 | 319 | 2021 |
| Routes of influenza transmission B Killingley, J Nguyen‐Van‐Tam Influenza and other respiratory viruses 7, 42-51, 2013 | 304 | 2013 |
Peter OpenshawProfessor of Experimental MedicineDirección de correo verificada de imperial.ac.uk
